We are closely associated with UCL Hospitals NHS Foundation Trust, Great Ormond Street Hospital, and the Royal Free Hospital NHS Foundation Trust.
This gives us greater clinical links than any comparable centre in the UK and has a huge impact on the delivery of clinical service to cancer patients.
The concentration of excellence, access to patients, and significant infrastructure, makes UCL a global leader in cancer research and treatment.
Our Departments at the UCL Cancer Institute
Department of Cancer Biology and Pathology
We research vital strands around cancer biology and pathology, including cell science, medical and regulatory genomics, and sarcoma biology.
Department of Clinical Trials
The Cancer Research UK and UCL Cancer Trials Centre forms the Clinical Trials research department within UCL Cancer Institute and is part of the Cancer Research UK-UCL Centre.
Department of Haematology
We research vital strands in Haematology, including immune regulation and immunotherapy, multiple myeloma and UCL's CAR-T programme.
Department of Oncology
We research vital strands in Oncology, including brain cancer biology, cancer metastasis, glioblastoma and treatment resistance.
Early Phase Cancer Trials
The Early Phase Cancer Trials Programme brings scientists and clinicians together to deliver ground breaking therapies for the treatment of cancer through clinical trials, with patients being at the heart of its research.
University College London / University College London Hospitals NHS Trust is a major research hub that showcases a vast portfolio of cancer research, collaborating with industry, partners and stakeholders from across the globe.
Early Phase Cancer Trials Programme at UCL & UCLH
The Early Phase Cancer Trials Programme brings together scientists and clinicians to deliver groundbreaking therapies for cancer treatment through clinical trials.
